0.10Open0.10Pre Close0 Volume6 Open Interest64.00Strike Price0.00Turnover200.19%IV20.36%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.0261Delta0.0063Gamma802.40Leverage Ratio-0.0999Theta-0.0001Rho-20.96Eff Leverage0.0029Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet